Washington Trust Bank’s Lifecore Biomedical LFCR Stock Holding History

Washington Trust Bank’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,000	Closed	-$12K	–	763
2015 Q3	$12K	Sell	1,000 -200	-17%	-$2.65K	﹤0.01%	595
2015 Q2	$17K	Hold	1,200	–	–	﹤0.01%	588
2015 Q1	$17K	Hold	1,200	–	–	﹤0.01%	596
2014 Q4	$17K	Sell	1,200 -600	-33%	-$7.75K	﹤0.01%	639
2014 Q3	$22K	Hold	1,800	–	–	0.01%	588
2014 Q2	$22K	Buy	+1,800	New	+$21.2K	﹤0.01%	604

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Washington Trust Bank's LFCR Position: Q4 2015 in Review

Washington Trust Bank sold out of Lifecore Biomedical (LFCR) in Q4 2015, closing a stake of 1,000 shares — an estimated $12K sold.

Washington Trust Bank first reported a position in LFCR in Q2 2014 and held it in 6 quarters. The position peaked at $22K in Q3 2014. 109 funds tracked by Wall St. Rank hold LFCR as of Q4 2015.

Washington Trust Bank reported no remaining Lifecore Biomedical position as of Q4 2015 after selling out during the quarter.
Washington Trust Bank sold 1,000 Lifecore Biomedical shares in Q4 2015, an estimated $12K.
Washington Trust Bank first reported a position in Lifecore Biomedical in Q2 2014 and held it in 6 quarters.
Washington Trust Bank's Lifecore Biomedical position peaked at $22K in Q3 2014.
109 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2015.

Based on Washington Trust Bank's 13F filing for Q4 2015, filed 21 Jan 2016.